Abstract
The extracellular signal-related kinase 1 and 2 (ERK1/2) pathway is a highly conserved signaling cascade with numerous essential functions in development. The scaffold protein Shoc2 amplifies the activity of the ERK1/2 pathway and is an essential modulator of a variety of signaling inputs. Germline mutations in Shoc2 are associated with the human developmental disease known as the Noonan-like syndrome with loose anagen hair. Clinical manifestations of this disease include congenital heart defects, developmental delays, distinctive facial abnormalities, reduced growth and cognitive deficits along with hair anomalies. The many molecular details of pathogenesis of the Noonan-like syndrome and related developmental disorders, cumulatively called RASopathies, remain poorly understood. Mouse knockouts for Shoc2 are embryonic lethal, emphasizing the need for additional animal models to study the role of Shoc2 in embryonic development. Here, we characterize a zebrafish shoc2 mutant, and show that Shoc2 is essential for development, and that its loss is detrimental for the development of the neural crest and for hematopoiesis. The zebrafish model of the Noonan-like syndrome described here provides a novel system for the study of structure–function analyses and for genetic screens in a tractable vertebrate system.
| Original language | English |
|---|---|
| Pages (from-to) | 501-514 |
| Number of pages | 14 |
| Journal | Human Molecular Genetics |
| Volume | 28 |
| Issue number | 3 |
| DOIs | |
| State | Published - Feb 1 2019 |
Bibliographical note
Publisher Copyright:© The Author(s) 2018. Published by Oxford University Press. All rights reserved.
Funding
National Cancer Institute (R00CA126161 to E.G.); National Institute of General Medical Sciences (GM113087 to E.G.); National Eye Institute (EY021769 to A.C.M.): American Cancer Society (RSG-14-172-01-CSM to E.G.); American Heart Association (15PRE25090207 to H.J.). We thank Drs Jessica Blackburn, Charles Waechter and Louis Hersh for providing reagents and critical reading of the manuscript. The UK Flow Cytometry and Cell Sorting core facility is supported in part by the UK Office of the Vice President for Research, the Markey Cancer Center and a National Cancer Institute Center Core Support Grant (P30 CA177558). We are also grateful to Sara Perkins, Chris Mitchell and Lucas Vieiro Francisco for zebrafish care.
| Funders | Funder number |
|---|---|
| Markey Cancer Center | |
| National Cancer Institute Cancer Nanotechnology Training Center | P30 CA177558 |
| American Cancer Society-Michigan Cancer Research Fund | RSG-14-172-01-CSM |
| American Cancer Society-Michigan Cancer Research Fund | |
| National Eye Institute/National Institutes of Health | EY021769 |
| National Eye Institute/National Institutes of Health | |
| National Childhood Cancer Registry – National Cancer Institute | R00CA126161, P30CA177558 |
| National Childhood Cancer Registry – National Cancer Institute | |
| National Institute of General Medical Sciences DP2GM119177 Sophie Dumont National Institute of General Medical Sciences | GM113087 |
| National Institute of General Medical Sciences DP2GM119177 Sophie Dumont National Institute of General Medical Sciences | |
| American the American Heart Association | 15PRE25090207 |
| American the American Heart Association | |
| Office of the Executive Vice President for Research and Partnerships, Purdue University |
ASJC Scopus subject areas
- Molecular Biology
- Genetics
- Genetics(clinical)